The results demonstrated that ConBR and DVL significantly inhibited 39 and 36% of cell death resulting from SARS-CoV-2WT infection, respectively, corroborating the antiviral activity of these lectins (Figure 4B). The gene discussed is DVL1; the disease is infection.